Skip to content
Recall Observatory FDA recall evidence

Exact FDA event identifier

Event 72177

22 recalled-product records grouped only because every row carries this exact official event ID.

Open FDA event record

Event summary

Timeline bucket
August 19, 2015
Product types
Drug
Classifications
Class II
Statuses
Terminated
Recalling firm wording
Pharmakon Pharmaceuticals

Dossier provenance

Source snapshots represented here

  • openFDA Drug Enforcement Report-date coverage June 20, 2012–July 08, 2026 Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.

Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.

How coverage and grouping work

Complete imported group

Every recalled product in this event

22 official enforcement rows

Product dates, classifications, firms, and source wording remain attached to their individual rows. Opening this dossier never hides products that did not match a prior timeline filter.

drug · product 1 of 22

Ephedrine Sulfate 5 mg/mL in 0.9% Sodium Chloride, injectable packed in syringes, Total dosage 25 mg/ 5mL, Rx only, PHARMAKON Pharmaceuticals, Inc.

D-0588-2016
Recall number
D-0588-2016
Initiated
August 19, 2015
Classification
Class II
Status
Terminated
Recalling firm
Pharmakon Pharmaceuticals
Quantity
4123

App-derived interpretation

Potency or specification failure reason.potency_specification_failure · v1.0.0
Stability data does not support expiry

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Stability data does not support expiry.

Code information

All lots with expiration dates up to 11/17/2015

Distribution pattern

Nationwide

drug · product 2 of 22

Epinephrine (PF) 10 mcg/mL in 0.9% Sodium Chloride, injectable packed in syringes, Total dosage 50 mg/ 5mL, Rx only, PHARMAKON Pharmaceuticals, Inc.

D-0589-2016
Recall number
D-0589-2016
Initiated
August 19, 2015
Classification
Class II
Status
Terminated
Recalling firm
Pharmakon Pharmaceuticals
Quantity
1150

App-derived interpretation

Potency or specification failure reason.potency_specification_failure · v1.0.0
Subpotent

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Subpotent drug.

Code information

All lots with expiration dates up to 11/17/2015

Distribution pattern

Nationwide

drug · product 3 of 22

Phenylephrine (PF) 100 mcg/mL in 0.9% Sodium Chloride, injectable packed in syringes, Total dosage 500 mcg/ 5mL, Rx only, PHARMAKON Pharmaceuticals, Inc.

D-0590-2016
Recall number
D-0590-2016
Initiated
August 19, 2015
Classification
Class II
Status
Terminated
Recalling firm
Pharmakon Pharmaceuticals
Quantity
N/A

App-derived interpretation

Potency or specification failure reason.potency_specification_failure · v1.0.0
Stability data does not support expiry

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Stability data does not support expiry.

Code information

All lots with expiration dates up to 11/17/2015

Distribution pattern

Nationwide

drug · product 4 of 22

Rocuronium 10 mg/mL, injectable packed in syringes, Total dosage 50 mg/ 5mL, Rx only, PHARMAKON Pharmaceuticals, Inc.

D-0591-2016
Recall number
D-0591-2016
Initiated
August 19, 2015
Classification
Class II
Status
Terminated
Recalling firm
Pharmakon Pharmaceuticals
Quantity
5875

App-derived interpretation

Potency or specification failure reason.potency_specification_failure · v1.0.0
Stability data does not support expiry

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Stability data does not support expiry.

Code information

All lots with expiration dates up to 11/17/2015

Distribution pattern

Nationwide

drug · product 5 of 22

Succinylcholine 20 mg/mL, injectable packed in syringes, Total dosage 100 mg/ 5mL, Rx only, PHARMAKON Pharmaceuticals, Inc.

D-0592-2016
Recall number
D-0592-2016
Initiated
August 19, 2015
Classification
Class II
Status
Terminated
Recalling firm
Pharmakon Pharmaceuticals
Quantity
2750

App-derived interpretation

Potency or specification failure reason.potency_specification_failure · v1.0.0
Stability data does not support expiry

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Stability data does not support expiry.

Code information

All lots with expiration dates up to 11/17/2015

Distribution pattern

Nationwide

drug · product 6 of 22

Midazolam (PF) 0.5 mg/mL in 0.9% Sodium Chloride, injectable packed in syringes, Total dosage 0.5 mg/ 1mL, Rx only, PHARMAKON Pharmaceuticals, Inc.

D-0593-2016
Recall number
D-0593-2016
Initiated
August 19, 2015
Classification
Class II
Status
Terminated
Recalling firm
Pharmakon Pharmaceuticals
Quantity
210

App-derived interpretation

Potency or specification failure reason.potency_specification_failure · v1.0.0
Subpotent

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Subpotent drug.

Code information

All lots with expiration dates up to 11/17/2015

Distribution pattern

Nationwide

drug · product 7 of 22

Ondansetron 2 mg/mL, injectable packed in syringes, Rx only, PHARMAKON Pharmaceuticals, Inc.

D-0594-2016
Recall number
D-0594-2016
Initiated
August 19, 2015
Classification
Class II
Status
Terminated
Recalling firm
Pharmakon Pharmaceuticals
Quantity
4100

App-derived interpretation

Potency or specification failure reason.potency_specification_failure · v1.0.0
Stability data does not support expiry

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Stability data does not support expiry.

Code information

All lots with expiration dates up to 11/17/2015

Distribution pattern

Nationwide

drug · product 8 of 22

Midazolam (PF) 0.1 mg/mL in 0.9% Sodium Chloride, injectable packed in syringes, Total dosage 0.2 mg/ 2mL, Rx only, PHARMAKON Pharmaceuticals, Inc.

D-0595-2016
Recall number
D-0595-2016
Initiated
August 19, 2015
Classification
Class II
Status
Terminated
Recalling firm
Pharmakon Pharmaceuticals
Quantity
665

App-derived interpretation

Potency or specification failure reason.potency_specification_failure · v1.0.0
Stability data does not support expiry

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Stability data does not support expiry.

Code information

All lots with expiration dates up to 11/17/2015

Distribution pattern

Nationwide

drug · product 9 of 22

Fentanyl Citrate (PF) 50 mcg/mL, injectable packed in syringes a) Total dosage 250 mcg/ 5mL, b) Total dosage 100 mcg/ 2mL, Rx only, PHARMAKON Pharmaceuticals, Inc.

D-0596-2016
Recall number
D-0596-2016
Initiated
August 19, 2015
Classification
Class II
Status
Terminated
Recalling firm
Pharmakon Pharmaceuticals
Quantity
7100

App-derived interpretation

Potency or specification failure reason.potency_specification_failure · v1.0.0
Stability data does not support expiry

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Stability data does not support expiry.

Code information

All lots with expiration dates up to 11/17/2015

Distribution pattern

Nationwide

drug · product 10 of 22

Morphine Sulfate (PF) 0.5 mg/mL in 0.9% Sodium Chloride, injectable packed in syringes, Total dosage 0.5 mg/ 1mL, Rx only, PHARMAKON Pharmaceuticals, Inc.

D-0597-2016
Recall number
D-0597-2016
Initiated
August 19, 2015
Classification
Class II
Status
Terminated
Recalling firm
Pharmakon Pharmaceuticals
Quantity
475

App-derived interpretation

Potency or specification failure reason.potency_specification_failure · v1.0.0
Stability data does not support expiry

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Stability data does not support expiry.

Code information

All lots with expiration dates up to 11/17/2015

Distribution pattern

Nationwide

drug · product 11 of 22

Hydromorphone HCl 1 mg/mL in 0.9% Sodium Chloride, injectable packed in syringes, Total dosage 1 mg/ 1mL, Rx only, PHARMAKON Pharmaceuticals, Inc.

D-0598-2016
Recall number
D-0598-2016
Initiated
August 19, 2015
Classification
Class II
Status
Terminated
Recalling firm
Pharmakon Pharmaceuticals
Quantity
8000

App-derived interpretation

Potency or specification failure reason.potency_specification_failure · v1.0.0
Stability data does not support expiry

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Stability data does not support expiry.

Code information

All lots with expiration dates up to 11/17/2015

Distribution pattern

Nationwide

drug · product 12 of 22

Glycopyrrolate 0.2 mg/mL, injectable packed in syringes, Total dosage 1 mg/ 5mL, Rx only, PHARMAKON Pharmaceuticals, Inc.

D-0599-2016
Recall number
D-0599-2016
Initiated
August 19, 2015
Classification
Class II
Status
Terminated
Recalling firm
Pharmakon Pharmaceuticals
Quantity
1530

App-derived interpretation

Potency or specification failure reason.potency_specification_failure · v1.0.0
Stability data does not support expiry

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Stability data does not support expiry.

Code information

All lots with expiration dates up to 11/17/2015

Distribution pattern

Nationwide

drug · product 13 of 22

Ketamine 100 mg/mL, injectable packed in syringes, Total dosage 100 mg/ 1mL, Rx only, PHARMAKON Pharmaceuticals, Inc.

D-0600-2016
Recall number
D-0600-2016
Initiated
August 19, 2015
Classification
Class II
Status
Terminated
Recalling firm
Pharmakon Pharmaceuticals
Quantity
600

App-derived interpretation

Potency or specification failure reason.potency_specification_failure · v1.0.0
Stability data does not support expiry

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Stability data does not support expiry.

Code information

All lots with expiration dates up to 11/17/2015

Distribution pattern

Nationwide

drug · product 14 of 22

Morphine Sulfate (PF) 0.1 mg/mL in 0.9% Sodium Chloride, injectable packed in syringes, Total dosage 0.1 mg/ 1mL, Rx only, PHARMAKON Pharmaceuticals, Inc.

D-0601-2016
Recall number
D-0601-2016
Initiated
August 19, 2015
Classification
Class II
Status
Terminated
Recalling firm
Pharmakon Pharmaceuticals
Quantity
525

App-derived interpretation

Potency or specification failure reason.potency_specification_failure · v1.0.0
Stability data does not support expiry

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Stability data does not support expiry.

Code information

All lots with expiration dates up to 11/17/2015

Distribution pattern

Nationwide

drug · product 15 of 22

Ketamine 50 mg/mL, injectable packed in syringes, Total dosage 50 mg/ 1mL, Rx only, PHARMAKON Pharmaceuticals, Inc.

D-0602-2016
Recall number
D-0602-2016
Initiated
August 19, 2015
Classification
Class II
Status
Terminated
Recalling firm
Pharmakon Pharmaceuticals
Quantity
250

App-derived interpretation

Potency or specification failure reason.potency_specification_failure · v1.0.0
Stability data does not support expiry

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Stability data does not support expiry.

Code information

All lots with expiration dates up to 11/17/2015

Distribution pattern

Nationwide

drug · product 16 of 22

Midazolam 1 mg/mL in 0.9% Sodium Chloride, injectable packed in syringes, Total dosage 2 mg/ 2mL, Rx only, PHARMAKON Pharmaceuticals, Inc.

D-0603-2016
Recall number
D-0603-2016
Initiated
August 19, 2015
Classification
Class II
Status
Terminated
Recalling firm
Pharmakon Pharmaceuticals
Quantity
5000

App-derived interpretation

Potency or specification failure reason.potency_specification_failure · v1.0.0
Stability data does not support expiry

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Stability data does not support expiry.

Code information

All lots with expiration dates up to 11/17/2015

Distribution pattern

Nationwide

drug · product 17 of 22

Lidocaine HCI (PF) Inj, USP 2%, injectable packed in syringes, Total dosage 100 mg/ 5mL, Rx only, PHARMAKON Pharmaceuticals, Inc.

D-0604-2016
Recall number
D-0604-2016
Initiated
August 19, 2015
Classification
Class II
Status
Terminated
Recalling firm
Pharmakon Pharmaceuticals
Quantity
400

App-derived interpretation

Potency or specification failure reason.potency_specification_failure · v1.0.0
Stability data does not support expiry

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Stability data does not support expiry.

Code information

All lots with expiration dates up to 11/17/2015

Distribution pattern

Nationwide

drug · product 18 of 22

Provocholine Pre-diluted Set II in 0.9% Sodium Chloride, 16 mg/mL, 3 mL in 5 mL Syr, injectable packed in syringes, Rx only, PHARMAKON Pharmaceuticals, Inc.

D-0605-2016
Recall number
D-0605-2016
Initiated
August 19, 2015
Classification
Class II
Status
Terminated
Recalling firm
Pharmakon Pharmaceuticals
Quantity
378

App-derived interpretation

Potency or specification failure reason.potency_specification_failure · v1.0.0
Stability data does not support expiry

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Stability data does not support expiry.

Code information

All lots with expiration dates up to 11/17/2015

Distribution pattern

Nationwide

drug · product 19 of 22

Provocholine Pre-diluted Set II in 0.9% Sodium Chloride, 4 mg/mL, 3 mL in 5 mL Syr, injectable packed in syringes, Rx only, PHARMAKON Pharmaceuticals, Inc.

D-0606-2016
Recall number
D-0606-2016
Initiated
August 19, 2015
Classification
Class II
Status
Terminated
Recalling firm
Pharmakon Pharmaceuticals
Quantity
N/A

App-derived interpretation

Potency or specification failure reason.potency_specification_failure · v1.0.0
Stability data does not support expiry

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Stability data does not support expiry.

Code information

All lots with expiration dates up to 11/17/2015

Distribution pattern

Nationwide

drug · product 20 of 22

Provocholine Pre-diluted Set II in 0.9% Sodium Chloride, 1 mg/mL, 3 mL in 5 mL Syr, injectable packed in syringes, Rx only, PHARMAKON Pharmaceuticals, Inc.

D-0607-2016
Recall number
D-0607-2016
Initiated
August 19, 2015
Classification
Class II
Status
Terminated
Recalling firm
Pharmakon Pharmaceuticals
Quantity
N/A

App-derived interpretation

Potency or specification failure reason.potency_specification_failure · v1.0.0
Stability data does not support expiry

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Stability data does not support expiry.

Code information

All lots with expiration dates up to 11/17/2015

Distribution pattern

Nationwide

drug · product 21 of 22

Provocholine Pre-diluted Set II in 0.9% Sodium Chloride, 0.25 mg/mL, 3 mL in 5 mL Syr, injectable packed in syringes, Rx only, PHARMAKON Pharmaceuticals, Inc.

D-0608-2016
Recall number
D-0608-2016
Initiated
August 19, 2015
Classification
Class II
Status
Terminated
Recalling firm
Pharmakon Pharmaceuticals
Quantity
N/A

App-derived interpretation

Potency or specification failure reason.potency_specification_failure · v1.0.0
Stability data does not support expiry

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Stability data does not support expiry.

Code information

All lots with expiration dates up to 11/17/2015

Distribution pattern

Nationwide

drug · product 22 of 22

Provocholine Pre-diluted Set II in 0.9% Sodium Chloride, 0.0625 mg/mL, 3 mL in 5 mL Syr, injectable packed in syringes, Rx only, PHARMAKON Pharmaceuticals, Inc.

D-0609-2016
Recall number
D-0609-2016
Initiated
August 19, 2015
Classification
Class II
Status
Terminated
Recalling firm
Pharmakon Pharmaceuticals
Quantity
N/A

App-derived interpretation

Potency or specification failure reason.potency_specification_failure · v1.0.0
Stability data does not support expiry

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Stability data does not support expiry.

Code information

All lots with expiration dates up to 11/17/2015

Distribution pattern

Nationwide